News
6h
Stockhead on MSNAntares Metals zeroes in on uranium potential at Mt IsaAntares Metals (ASX:AM5) said this highlighted the strong potential of the uranium prospectivity at Mt Isa North. The Queens ...
Antares Vision Group has collaborated with Oròbix to create AI-GO, an artificial intelligence-driven visual inspection ...
Antares Legal advised SAMHI Hotels Ltd. on its strategic partnership with Singapore's sovereign wealth fund, GIC, for an ...
Antares Therapeutics, Inc. ("Antares"), a biotechnology company developing first-in-class precision medicines for cancer and ...
2h
Stockhead on MSNClosing Bell: ASX surges as missiles fly ahead of Iran-Israel ceasefireThe ASX lifted 1pc as the Iran-Israel ceasefire loomed today. Materials and financials lead gains, while the energy sector ...
12d
Pharmaceutical Technology on MSNAntares Therapeutics gains $177m for cancer medicines developmentAntares Therapeutics has secured $177m in Series A financing round for the development of precision medicines.
Five months after selling a cancer drug to Lilly for up to $2.5 billion, Scorpion has debuted a successor company led by its ...
14d
Astronomy on MSNThe Sky Today on Tuesday, June 10: The Moon meets AntaresA nearly Full Moon passes close to the ruby-red star at the heart of the Scorpion, visible in the early-morning hours.
Late last month, Firefly announced that Northrop Grumman has invested $50 million into accelerating the development of the ...
The waxing gibbous moon will shine close to the red star Antares in the constellation Scorpius on the night of June 9.
When Eli Lilly snapped up Scorpion Therapeutics' PI3Kα program earlier this year, the deal allowed Scorpion to spin out a new entity that would house its preclinical pipeline. | Antares may be forging ...
Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results